SodiUm SeleniTe Administration IN Cardiac Surgery (SUSTAIN CSXÂ®-trial). A pilot randomized controlled trial of high dose sodium-selenite administration in high risk cardiac surgical patients.
The SUSTAIN CSX represents collaboration between CERU, the Clinical Trial Centre- Aachen and an industry partner Biosyn Arzneimittel GmbH to investigate the effects of high dose sodium-selenite on high risk cardiac surgical patients. Subjects will be recruited in Canada, and Germany.
Study status: Start-up PhaseGerman lead Investigator Dr. Christian Stoppe at a recent Investigatorâ€™s meeting in Frankfurt, Germany.
This trial is registered on ClinicalTrials.gov: NCT 02002247